Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.660
+0.110 (7.10%)
Jun 6, 2025, 4:00 PM - Market closed
Cibus Employees
As of December 31, 2024, Cibus had 159 total employees, including 157 full-time and 2 part-time employees. The number of employees decreased by 24 or -13.11% compared to the previous year.
Employees
159
Change (1Y)
-24
Growth (1Y)
-13.11%
Revenue / Employee
$29,881
Profits / Employee
-$1,728,547
Market Cap
83.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CBUS News
- 2 days ago - USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations - GlobeNewsWire
- 3 days ago - Cibus, Inc. Announces Pricing of $27.5 Million Public Offering - GlobeNewsWire
- 4 days ago - Cibus, Inc. Announces Proposed Public Offering - GlobeNewsWire
- 12 days ago - Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat - GlobeNewsWire
- 20 days ago - Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase - GlobeNewsWire
- 4 weeks ago - Cibus, Inc. (CBUS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - GlobeNewsWire
- 4 weeks ago - Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding - GlobeNewsWire